Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis. Davies L, Shehadeh R, Watkins WJ, Jolles S, et al. J Neurol 2025;272:415.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Davies L, Shehadeh R, Watkins WJ, Jolles S, et al. Real-world observational study of infections in people treated with ocrelizumab for multiple sclerosis. J Neurol 2025;272:415.
PMID: 40402264